Effectiveness of Platform-Based Lateralization Therapy in Reducing Interface Pressure Between The Patient And The Support Surface

Recruiting N/A Interventional Study
Respiratory Insufficiency Pressure Injury Intensive Care Medicine ARDS
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
25 (estimated)
Sponsor
University of Sao Paulo General Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Pressure injury (PI) is characterized as damage to the skin and/or underlying tissues resulting from sustained pressure or a combination of pressure and shear forces between the patient and the support surface. Prolonged pressure is a well-established risk factor in the development of PIs. Frequent repositioning and routine patient care have been recognized for decades as integral components of PI…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria * Adult and elderly patients, aged 18 years or older; * Patients under controlled or assisted mechanical ventilation, not yet eligible for weaning. Exclusion Criteria * Requirement of norepinephrine \> 0.3 mcg/kg/min or mean arterial pressure \< 60 mmHg, despite the use of vaso…
Contacts

Marcelo BP Amato, MD PhD

+55113061-7361

marcelo.amato@hc.fm.usp.br

CONTACT

Anne C Almeida de Sousa, PT

+5579998577249

anne.sousa@usp.br

CONTACT